| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/02/1997 | EP0781776A2 Water soluble rapamycin esters |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
| 07/02/1997 | EP0781277A1 Neurokinin antagonists |
| 07/02/1997 | EP0730588B1 Isoxazoline compounds as antiinflammatory agents |
| 07/02/1997 | EP0522082B1 Multi-functional pharmaceutical compounds and methods of use |
| 07/02/1997 | CN1153478A Chinese herbs extract |
| 07/02/1997 | CN1153176A Stable crystalline tetrahydrofolic acid salts |
| 07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
| 07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643946 Compounds useful for treating allergic and inflammatory diseases |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |
| 07/01/1997 | US5643893 Antiinflammatory agents or antiarthritic agents |
| 07/01/1997 | US5643875 Proteins and endotoxins |
| 07/01/1997 | US5643870 Topical asthma treatment |
| 07/01/1997 | US5643868 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643598 Method of skin care utilizing liposomes containing Scutellaria extracts |
| 06/26/1997 | WO1997022722A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022613A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments |
| 06/26/1997 | WO1997022604A1 Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| 06/26/1997 | WO1997022364A1 FCε-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 06/26/1997 | WO1997022344A1 Process for production of piperidine derivatives |
| 06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
| 06/26/1997 | WO1997010005A3 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | CA2241371A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/26/1997 | CA2240366A1 New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 06/25/1997 | EP0779888A1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 06/25/1997 | CN1152939A Monoclonal antibodies which promote central nervous system remyelination |
| 06/25/1997 | CN1152915A Quinoline derivatives as leukotriene antagonists |
| 06/25/1997 | CN1152874A Copolymer-1 improvements in compositions of copolymers |
| 06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
| 06/25/1997 | CN1152573A Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |
| 06/25/1997 | CN1152435A Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside |
| 06/25/1997 | CN1035255C Heterotricyclic derivatives |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641870 Low pH hydrophobic interaction chromatography for antibody purification |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641805 Topical ophthalmic formulations for treating allergic eye diseases |
| 06/24/1997 | US5641803 Injecting regulated dosages over a shorter time period causes less myelosuppression and hematologic toxicity |
| 06/24/1997 | US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis |
| 06/24/1997 | US5641789 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641757 Stable 2-chloro-2'-deoxyadenosine formulations |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/19/1997 | WO1997021826A2 Complementary adenoviral vector systems and cell lines |
| 06/19/1997 | WO1997021819A1 Novel nagpu |
| 06/19/1997 | WO1997021716A1 NAPHTHYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021692A1 Novel compounds and methods for treating multiple sclerosis |
| 06/19/1997 | WO1997021682A1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity |
| 06/19/1997 | WO1997021670A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 06/19/1997 | WO1997021664A1 NAPHTHYL ACETAMIDES AS sPLA2 INHIBITORS |
| 06/19/1997 | WO1997021444A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | WO1997021435A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997011666A3 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 06/19/1997 | DE19546452A1 Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel New Phenylamidinderivate, processes for their Herstelung and their use as medicaments |
| 06/19/1997 | CA2273983A1 Process for the preparation of 9-deazaguanine derivatives |
| 06/19/1997 | CA2240395A1 Naphthyl acetamides as spla2 inhibitors |
| 06/19/1997 | CA2240115A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2239874A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | CA2212371A1 Novel compounds and methods for treating multiple sclerosis |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0779282A1 Thiomorpholinone compounds for treating multiple sclerosis |
| 06/18/1997 | EP0779273A1 Naphthyl glyoxamides as sPLA2 inhibitors |
| 06/18/1997 | EP0779271A1 Naphthyl acetamides as sPLA2 inhibitors |
| 06/18/1997 | EP0778847A1 Immunostimulatory agents |
| 06/18/1997 | EP0778780A1 Capsular polysaccharide immunomodulator |
| 06/18/1997 | EP0710110A4 Rapamycin conjugates and antibodies |
| 06/18/1997 | EP0662953B1 Novel vitamin d analogues |
| 06/18/1997 | EP0580635B1 Modified plant viruses as vectors |
| 06/18/1997 | EP0512064B1 Extracellular segments of human ige immunoglobulin anchoring peptides and antibodies specific therefor |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1151892A Superfine plant worm powder and its product |
| 06/18/1997 | CN1035177C Prep. of 20-methyl-substituted vitamin D-derivatives |
| 06/17/1997 | US5639947 Genetic engineering |
| 06/17/1997 | US5639902 (Cyclohexyl)alkene compounds |
| 06/17/1997 | US5639858 Polypeptide |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639852 Analogs of cyclosporin a |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639782 Antiinflammatory agent; antiallergens |
| 06/17/1997 | US5639768 Leukototriene receptor antagonist; antinflammatory agents |
| 06/17/1997 | US5639759 Organ transplantation; autoimmune diseases, antiinflammatory agents; skin disorders; antiarthritic agents; anticancer agents |
| 06/17/1997 | US5639745 Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
| 06/17/1997 | US5639729 Tripeptides useful in immune and CNS therapy |